Brooklyn Immunotherapeutics Inc - ESG Rating & Company Profile powered by AI
Check the end of this webpage for potential risks for Brooklyn Immunotherapeutics Inc based on sector, geography and marketcap. The report of Brooklyn Immunotherapeutics Inc uses data from across the internet as well as from public disclosures by Brooklyn Immunotherapeutics Inc. Complete ESG analysis of Brooklyn Immunotherapeutics Inc can be accessed by signing up for free.
Brooklyn Immunotherapeutics Inc in the Movies & Entertainment industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Borussia Dortmund GmbH & Co KGaA | 8.0 | High |
| 1 | AIK Fotboll AB | 8.0 | High |
| ... | ... | ... | |
| 191 | Nan Hai Corporation Ltd | 0.5 | Low |
| 191 | G H Y Culture & Media Holding Co Ltd | 0.5 | Low |
| 195 | Brooklyn Immunotherapeutics Inc | 0.0 | Low |
| 195 | CDA SA | 0.0 | Low |
| 195 | CJ CGV Co Ltd | 0.0 | Low |
| 195 | iQIYI Inc | 0.0 | Low |
| 195 | m4e AG | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Brooklyn Immunotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc offer flexible work?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Brooklyn Immunotherapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Brooklyn Immunotherapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Brooklyn Immunotherapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Brooklyn Immunotherapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Brooklyn Immunotherapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Brooklyn Immunotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.